NFE2L2 and cardiovascular disorder: The deregulation of NRF2 signaling often precedes or exacerbates the progression of cardiovascular diseases (CVDs), and an increasing body of evidence supports the concept that boosting NRF2 levels, particularly during the early stages of cellular damage, reduces cell vulnerability and preserves cardiovascular system health.